key: cord-0738640-vgupph9k authors: Ibrahim, Ahmed Elsayed; Magdy, Mayar; Khalaf, Eslam M.; Mostafa, Alshimaa; Arafa, Ahmed title: Teledermatology in the time of COVID‐19 date: 2021-11-04 journal: Int J Clin Pract DOI: 10.1111/ijcp.15000 sha: e9f532c0febca2ff7de8056c1033a6172d11130d doc_id: 738640 cord_uid: vgupph9k AIMS: The enormous spread of the novel Corona virus disease (COVID‐19) represents a challenge to dermatological practice. Accumulating evidence has suggested a possible role of teledermatology in facing this challenge. In this article, we aimed to give a general overview of teledermatology in terms of models of practice, modes of delivery, advantages, limitations, ethical considerations and legislative challenges as well as discussing, using examples from literature, how dermatological practice can benefit from teledermatology during the time of the COVID‐19 pandemic. DISCUSSION AND CONCLUSION: Teledermatology could be an accessible, accurate and cost‐effective substitute for conventional face‐to‐face dermatological consultations during the COVID‐19 pandemic. However, teledermatology practice needs updated legislation and guidelines. More efforts should be done to encourage dermatologists, especially in underserved communities, to provide teledermatology services. Ethical issues and data security related to teledermatology have to be considered. The novel Corona virus disease (COVID-19) pandemic represents a challenge to healthcare systems and medical practice worldwide. Dermatology practice is amongst the most affected medical disciplines because dermatological examination requires close inspection that is currently advised to be avoided to prevent the spread of COVID-19. 1 Routine investigations, screenings, elective surgeries and follow-ups have been also discouraged as the hospitals and clinics could be sources of infection. 2 Besides, several dermatologists had to get home or hospital isolated for being infected or contacting patients with COVID-19. 3 These factors together have restricted access to dermatological care and reduced the capacity of dermatological practice. Opposed to the limited access and capacity of dermatological practice in the time of COVID- 19 , there has been a concurrent increase in the need for dermatological care for many reasons. First, the protective measures of COVID-19 including regular handwashing, the repeated use of hand sanitisers and wearing personal protective equipment for a long time have resulted in a noticeable increase in dermatitis and worsening of other dermatological conditions. 4 Second, COVID-19, per se, has been shown to present with dermatological manifestations including erythematous rash, chilblain-like lesions, vesicular chickenpox-like exanthem and urticarial rash. [5] [6] [7] Third, several patients with chronic dermatological conditions had to consult their dermatologists regarding the use of immunosuppressive and immunomodulating systemic therapies for their possible interactions with COVID-19. 8 Fourth, relieving lockdown measurements in most countries is expected to be associated with a surge in elective dermatological consultations and surgeries. To fill the gap between the limited access to dermatological care and the growing need for this care, digital approaches have been considered. Of these approaches, teledermatology can be a timely solution for many of the challenges facing dermatological practice during the time of the COVID-19 pandemic. Teledermatology is the use of telecommunications technologies to allow the remote exchange of medical information related to dermatological conditions. The advances in audio, visual and data telecommunication technologies have made it easier for physicians to communicate with remotely situated patients. 9 This is particularly relevant to dermatology as visual cues are the keystone in identifying most dermatological pathologies. Images or videos of dermatological conditions can be remotely viewed by a dermatologist who can make a diagnosis and start a management plan for patients. In this article, we aimed to give a general overview of teledermatology in terms of models of practice, modes of delivery, advantages, limitations, ethical considerations and legislative challenges as well as discussing, using examples from literature, how dermatological practice can benefit from teledermatology during the time of the COVID-19 pandemic. There are four main models of teledermatology practice: (a) consultation: in which the referring physician consults the dermatologist regarding the patient's dermatological condition, (b) triage: in which dermatologists decide on the priority of management and referrals, (c) direct care: in which dermatologists consult their patients using video conference or patients directly send pictures of dermatological lesions to their dermatologists and (d) follow-up: in which dermatologists monitor the dermatological condition and its response to treatment. 10 There are three types of technological models used for delivering teledermatology services: synchronous, asynchronous and hybrid. In this model, there is real-time communication between the dermatologist and the patient or the referring physician. This is usually done via a live video conference. On the one hand, it allows dermatologists to provide patients with an experience that is more similar to face-to-face consultation on an interpersonal level. Dermatologists can ask patients about their manifestations and clinical history before receiving a quick response. This can make it more efficient for patients to be diagnosed and managed in a time-saving manner. On the other hand, this model requires previous coordination to decide on a time that is suitable for both parties which can be challenging in instances where there is a significant difference in time zones. It can also be a problem for people who do not have access to highspeed internet as video conferences require significant bandwidth. Another issue is that video quality can be lower than that of still images. Also, some patients may not be comfortable with showing sensitive areas of their bodies through a webcam. 11-13 In this model, the patient or the referring physician can take a still images with or without a text history to the dermatologist who makes a phone call with the sender to discuss the image and the case. Hybrid teledermatology can overcome the disadvantages of both models by providing dermatologists with a time-saving interview with the patient or the referring physician as well as a highquality image of the dermatological condition. 12 During the COVID-19 pandemic, dermatological patients, thanks to teledermatology, can be diagnosed and monitored at home; thus, they can avoid exposure to infection at medical facilities. Teledermatology can also offer broader coverage of dermatological care along with other advantages such as cutting travel time and reducing the time required to obtain a diagnosis and initiate treatment. 14, 15 Access to teledermatology services has been established in countries with developed healthcare systems that have allowed patients to obtain dermatological care during the COVID-19 pandemic. In two university hospitals in France, for example, teledermatology was able to act as a substitute for face-to-face visits in managing non-COVID-19 and COVID-19-related dermatological conditions. 16 On the other hand, the access to dermatological care in low-and middle-income countries and rural areas is very limited because of the low ratio of dermatologists per capita and their skewed urban allocation in addition to the lack of established platforms for teledermatology. However, this pandemic can be a good opportunity to begin applying teledermatology in these countries. In Egypt, for example, many dermatologists started to provide synchronous and asynchronous teledermatology services during the COVID-19 pandemic. Most patients who received these services reported their usefulness, learnability and reliability whilst the dermatologists expressed their readiness to offer and expand their teledermatology services. 17, 18 Also, previous teledermatology programmes have been able to complement dermatological care to residents of rural areas. 19 However, the lack of appropriate technology to access teledermatology remains a challenge that could exacerbate health disparities amongst underserved populations. 20 Besides, elderly and illiterate patients may find teledermatology platforms difficult to use. In this regard, Simpson and Kovarik 21 have suggested some tips that can help people with limited knowledge of technology engage effectively in teledermatology such as reducing the steps to connect, providing simple instructions, offering a trial run and utilising multiparty encounters. We believe that such ideas side by side with other ideas that involve simplifying teledermatology delivery models should be prioritised to guarantee broader access. Teledermatology has nearly similar diagnostic and management accuracy compared with face-to-face consultations and has even more accuracy than general practice with insufficient dermatology training. 14 A study conducted in Switzerland to detect the diagnostic accuracy of teledermatology in 195 dermatological lesions showed that teledermatology alone was suitable to carry out skin cancer screening with 100% sensitivity and 76.6% specificity. When conventional teledermatology was combined with dermoscopic images, the specificity increased to 84.9%, allowing the reduction of unnecessary testing in a larger proportion of dermatological lesions. 22 Teledermatology aided by teledermoscopy was even more accurate in diagnosing cancer than direct referral amongst 59,279 primary care patients in Brazil. 23 In two randomised clinical trials, teledermatology was as effective as in-person management in improving clinical outcomes of patients with atopic dermatitis and psoriasis. 24, 25 However, the accuracy of teledermatology in identifying dermatological conditions attributed to COVID-19 infection needs to be studied. Costs of teledermatology include direct costs for hardware and staff training and indirect costs for software services, internet connections and medical insurance. 26 However, compared with face-to-face consultation, teledermatology was found to be costeffective through reducing inpatient visits and referral to secondary care, saving transportation time and expenses, minimising lost work productivity, sparing costs of companions in the case of children and disabled patients and avoiding drawbacks of a delayed diagnosis. 27, 28 Moreover, during the COVID-19 pandemic, teledermatology has been shown to save the costs of protective equipment. 15 Also, preventing patients and dermatologists from getting infected with COVID-19 via teledermatology can minimise huge costs. Obtaining informed consent before conducting the clinical assessment is essential. Alike, teledermatology necessitates informed consent in which the patient should understand the characteristics of teledermatology, policies regarding using webcams and saving or deleting photos and data security issues. 29 However, it is a matter of debate whether the patient should receive an online or videorecorded explanation of informed consent, or the patient reads his/ her electronic informed consent. Another debate is rising about whether the patient has to sign a paper-based informed consent and upload the scan or could simply sign electronic informed consent by clicking agree or typing name. [30] [31] [32] One point of view considers that when a patient sends an unsolicited consultation to the dermatologist including his/her photos and clinical history, this should be considered a conscious autonomous decision that can replace the need for written informed consent. Amongst underserved communities that have no access to established teledermatology services, patients use social networks to send photos of their lesions directly to their dermatologists in private messages. This approach is very common in developing countries and usually does not include signing informed consent, and dermatologists perceive receiving a phone call or messages of dermatological lesions from patients as consent. 33 Social distancing measures imposed because of the COVID-19 pandemic including work from home have urged the need for tighter data protection regulations. Through teledermatology, patients may send photos of sensitive body parts and some of them are concerned that teledermatology carries the risk of privacy breach during data transmission, storage on a web server or involvement of other physicians. 30 Personal data leakage could be prevented by pseudo anonymisation (replacing patients' identifying data with codes), limiting access to authorised personnel, entity authentication, data encryption via usernames and passwords, virus scanning and filtering electronic feeds. 34 Dermatologists also should be educated on how to protect teledermatology patients' privacy by, for example, deleting photos and medical history saved on their devices immediately after updating their electronic medical records and also having enough technical skills to ensure the security of their devices and methods of communication with patients. 35 To draft this section, we conducted a rapid systematic review of articles that investigated teledermatology practices during the COVID-19 pandemic. Using the terms (teledermatology OR online dermatology) AND (COVID-19), we searched PubMed for related articles published in English before 1 September 2021 (n = 285). Then, we conducted a manual search of the reference lists of retrieved studies to obtain further studies. We considered full manuscripts, brief reports, editorials and letters. Eventually, we extracted and tabulated the following information from 26 selected studies: the last name of the first author, study location, subjects, study design, outcomes and significant findings (Table 1 ). Whilst many dermatology clinics decided to close or reduce their capacity, others chose teledermatology. In Italy, Cinelli et al 36 restricted the face-to-face consultation to urgent visits and surgical procedures and conducted the rest of the consultations via online video, telephone and e-mails. The authors showed that amongst 105 patients with dermatological complications under cancer therapy, 87 patients could be treated using teledermatology. Also, Brunasso and Massone, 37 in a tertiary centre in Italy, replaced all scheduled follow-up visits of patients with chronic dermatological disorders with phone calls and e-mailed photos when needed. Only 3% reported deterioration of their condition requiring in-person visits and teledermatology was effective in assurance, withdrawal and adding or switching drugs in the rest of the patients. In the United States, asynchronous teledermatology services were offered for suspected COVID-19 with dermatological conditions. These services were able to treat more than two-thirds of patients, avoid unnecessary personal and preserve protective equipment. 38 Still, it could be argued that whilst planned elective dermatological surgeries can be postponed, delaying surgery for skin malignancies can worsen the prognosis and eventually increase the treatment costs. 39 However, presurgery evaluation can be done through live video or phone calls whether at home or in a designed room in the hospital. 40 Many hospitals had to withhold their dermatology inpatient services because of the high possibility of admitting patients with COVID-19. For example, 18% of the admitted patients in a tertiary hospital in Turkey who were presented to the inpatient dermatology clinic were COVID-19 suspects. 41 Thus, the utilisation of teledermatology for inpatients is crucial in terms of minimising the risk of COVID-19 exposure and reducing the consumption of protective equipment. 42 Taking pictures of skin lesions of the admitted COVID-19 patients and forwarding them to dermatologists allowed early diagnosis and treatment of their dermatological conditions. 43 Dermoscopy is a noninvasive tool that aids in the diagnosis of numerous dermatological disorders. However, dermoscopic lenses and buttons were found to be contaminated with microorganisms acquired through patient contact and were suggested to be sources of COVID-19 infection. 44, 45 During the COVID-19 pandemic, teledermoscopy could be viewed as a better option compared to face-to-face examination as it reduces unnecessary referrals and waiting times; therefore, it could reduce the risk of cross-infection. Furthermore, it poses a good diagnostic accuracy compared with face-to-face consultation and histopathological diagnoses. Also, self-examination makes some patients feel more comfortable. 11, 46 Teledermoscopy photos can be obtained through mobile equipped with dermoscopic attachment either by patients themselves or by their referring physicians whilst consulting dermatologists through asynchronous teledermatology. While the attachment can be sent to consumers via mail, a clear policy is still lacking on how to provide mobile teledermoscopy and who will pay for them. 47-50 Because of the COVID-19 pandemic, most hospitals and medical schools cancelled or postponed their clinical educational classes, medical trainees were discouraged to attend outpatient clinics and ward rounds and many scientific meetings and conferences were cancelled. These disruptions did not just affect the academic process but the knowledge and experience of residents and trainees as well. Teledermatology, however, can offer platforms for training residents and exchanging knowledge between dermatologists worldwide. 13, 51 In a pioneering experience, Harvard Medical School designed a teledermatology rotation for medical students including synchronous and asynchronous visits and consultations. During this rotation, students were able to preview teleconsultations and develop a differential diagnosis and management plan for the most common dermatological conditions. They could also learn via online visits about monitoring chronic dermatological conditions. 52 Hence, we believe that including teledermatology in medical education and training medical students and residents on its use should be taken seriously. Since the beginning of the COVID-19 pandemic, a dramatic decrease in elective surgeries was noted and at the heart of these cosmetic surgeries. One study surveyed 100 dermatologists working in private dermatocosmetology clinics who described how heavily COVID-19 hit their businesses. 53 Certain procedures carry a high Still, many teledermatology services, especially direct teledermatology, lack obvious reimbursement policies in the case of treating patients covered with health insurance. 27 This lack of these policies is accompanied by shortages in the legislations that regulate teledermatology because of the rapid progress of technologies that exceed the updates in legislations, and there is even a lack of teledermatology legislations in many areas of the world. It should be noted that healthcare systems and their financing methods differ significantly across the world; therefore, we cannot claim that a certain healthcare system or a certain financing method is better than the other when it comes to teledermatology practices. Therefore, lawmakers, healthcare givers and health insurance companies have to work on new flexible legislations that guarantee the delivery of teledermatology care of quality to patients alongside funding start-ups in teledermatology applications and encouraging more dermatologists to offer teledermatology services by providing them with training, technical support and legal counselling. Besides, reliable mechanisms for reimbursement should be determined to encourage more dermatologists to invest in teledermatology. In conclusion, teledermatology can offer a convenient way of expanding access to dermatological care in cost-effective, accurate and efficient ways whilst minimising the risk of COVID-19 transmission. More efforts should be exerted to provide dermatologists and patients with the technical support needed for teledermatology. Legislations and guidelines for putting teledermatology in practice whilst protecting patient privacy and data security are needed. The authors declare no conflict of interest. All authors contributed to writing, editing and revising this manuscript. Data sharing does not apply to this article as no datasets were generated or analysed during the current study. Dermatologists and SARS-COV-2: the impact of the pandemic on daily practice Which dermatology patients attend to dermatology outpatient Clinics during the SARS-CoV -2 outbreak in Turkey and what happened to them? Impact of covid -19 outbreak on dermatology services: Dermatology in isolation Skin damage among health care workers managing coronavirus disease-2019 Cutaneous manifestations in COVID-19: a first perspective Pernio-like skin lesions associated with covid-19: a case series of 318 patients from 8 countries Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: a diagnostic clue? Covid-19-related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test Telemedicine in dermatology: Findings and experiences worldwide -a systematic literature review Health-care delivery methods in teledermatology: Consultative, triage and direct-care models Teledermatology: A review and update Teledermatology: From historical perspective to emerging techniques of the modern era Teledermatology and its current perspective Recent trends in teledermatology and teledermoscopy Telemedicine in the face of the COVID-19 pandemic Teledermatology for COVID-19 cutaneous lesions: substitute or supplement? Dermatological consultations in the COVID-19 era: is teledermatology the key to social distancing? An Egyptian experience Egyptian dermatologists attitude toward telemedicine amidst the COVID19 pandemic: a cross-sectional study Implementing teledermatology for rural veterans: an evaluation using the RE-AIM Framework Telemedicine and the battle for health equity: translating temporary regulatory orders into sustained policy change Effectively engaging geriatric patients via teledermatology Mobile teledermatology for skin cancer screening: a diagnostic accuracy study Comparative effectiveness study of face-to-face and teledermatology workflows for diagnosing skin cancer Online care versus in-person care for improving quality of life in psoriasis: a randomized controlled equivalency trial Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial Two decades of teledermatology: current status and integration in national healthcare systems Group for Research of Policy Dynamics in Dermatology. Clinical effectiveness and costeffectiveness of teledermatology: where are we now, and what are the barriers to adoption? A patient-centric cost analysis of store-and-forward teledermatology Telemedicine practice: review of the current ethical and legal challenges Application of ethics for providing telemedicine services and information technology Etherapy: the ethics behind the process Telehealth and legal implications for nurse practitioners Exploring practices of dermatologists in ethical dilemmas in Pakistan: a narrative analysis Perspectives of online surveys in dermatology Teledermatology and clinical photography: safeguarding patient privacy and mitigating medicolegal risk Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during COVID-19 emergency in a tertiary center in Italy Store-and-forward teledermatology in the era of COVID-19: a pilot study The danger of neglecting melanoma during the COVID-19 pandemic The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian red-zone Evaluation of dermatology consultations in the era of COVID-19 Inpatient teledermatology during the COVID-19 pandemic Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department Prevention of possible cross-infection among patients by dermoscopy: a brief review of the literature and our suggestion Dermoscopy practice during COVID-19 pandemic: recommendations by SIG Dermoscopy (IADVL Academy) Teledermoscopy for skin cancer prevention: A comparative study of clinical and teledermoscopic diagnosis Consumer preferences for skin cancer screening using mobile teledermoscopy: a qualitative study Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial Current economic evidence for teledermoscopy Diagnostic concordance in tertiary (dermatologists-to-experts) teledermoscopy: a final diagnosis-based study on 290 Cases Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic Asynchronous teledermatology in medical education: lessons from the COVID-19 pandemic Medical and socioeconomic challenges of private dermatocosmetology clinics during COVID-19 pandemic: a survey from Turkey Re facial aesthetic injections in clinical practice: Pretreatment and post-treatment consensus recommendations to minimise adverse outcome region-specific changes in line with the Covid-19 pandemic Patient education in Mohs surgery: a review and critical evaluation of techniques Reimbursement for teledermatology in the United states: a review Teledermatology in times of COVID-19 confinement: comparing patients' and physicians' satisfaction by the standardized Brest teledermatology questionnaire Impact of the Covid-19 pandemic on dermatology practice worldwide: results of a survey promoted by the International Dermoscopy Society (IDS) Utilization of asynchronous and Synchronous teledermatology in a large health care system during the Covid-19 pandemic Differences in utilization of nonvideo telemedicine visits for dermatologic concerns in underserved populations during the Covid-19 pandemic Management of patients with atopic Dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the Da-covid-19 registry Direct-to-patient teledermatology during COVID-19 lockdown in a health district in Madrid, Spain: the EVIDE-19 pilot study Teledermatology in the times of COVID-19 -a systematic review Analysis of availability, types, and implementation of teledermatology services during COVID-19 Will teledermatology be the silver lining during and after COVID-19? Teledermatology for acne patients: how to reduce face-to-face visits during COVID-19 pandemic Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency Teledermatology in the era of COVID-19: experience of an academic department of dermatology Views and experiences of dermatologists in Turkey about teledermatology during the COVID-19 pandemic A survey on teledermatology use and doctors' perception in times of COVID-19 Patient perceptions and satisfaction with teledermatology during the COVID-19 pandemic: a survey-based study Teledermatology in times of COVID-19 Impact of COVID-19 pandemic on dermatology practices: results of a web-based, global survey Teledermatology during the COVID-19 pandemic: experience at a tertiary care centre in North India Australian Teledermatology experience during COVID-19 Expansion of asynchronous teledermatology during the COVID-19 pandemic Comment on "Rescheduling of clinical activities and teleconsulting for public dermatology. Two prompt answers to COVID-19 emergency Photo-triage of infantile hemangiomas: potential to reduce healthcare exposure in the COVID19 pandemic Teledermatology in the time of COVID-19